Literature DB >> 20003031

Prevalence of anti-HLA antibodies after liver transplantation.

Massimiliano Fontana, Darius Moradpour, Vincent Aubert, Giuseppe Pantaleo, Manuel Pascual.   

Abstract

Mesh:

Substances:

Year:  2009        PMID: 20003031     DOI: 10.1111/j.1432-2277.2009.01022.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


× No keyword cloud information.
  4 in total

1.  High mean fluorescence intensity donor-specific anti-HLA antibodies associated with chronic rejection Postliver transplant.

Authors:  J G O'Leary; H Kaneku; B M Susskind; L W Jennings; M A Neri; G L Davis; G B Klintmalm; P I Terasaki
Journal:  Am J Transplant       Date:  2011-06-14       Impact factor: 8.086

2.  Donor-specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver Transplantation.

Authors:  Laura J Wozniak; Michelle J Hickey; Robert S Venick; Jorge H Vargas; Douglas G Farmer; Ronald W Busuttil; Sue V McDiarmid; Elaine F Reed
Journal:  Transplantation       Date:  2015-07       Impact factor: 4.939

Review 3.  Clinical significance of donor-specific human leukocyte antigen antibodies in liver transplantation.

Authors:  Antonio Cuadrado; David San Segundo; Marcos López-Hoyos; Javier Crespo; Emilio Fábrega
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

4.  De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients.

Authors:  H Kaneku; J G O'Leary; N Banuelos; L W Jennings; B M Susskind; G B Klintmalm; P I Terasaki
Journal:  Am J Transplant       Date:  2013-06       Impact factor: 8.086

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.